COFOE Medical sets IPO price at HK$39.33, raising HK$1.01 billion; Hong Kong tranche 399 times subscribed

Bulletin Express05-05

Cofoe Medical Technology Co., Ltd. (abbrev. “COFOE”) has finalised the terms of its Hong Kong IPO, offering 27.00 million H shares at HK$39.33 each. The transaction delivers gross proceeds of HK$1.06 billion and net proceeds of HK$1.01 billion after estimated expenses. Trading is scheduled to commence on 6 May 2026 under the stock short name “COFOE”.

Offer structure and demand • Hong Kong Public Offering: 2.70 million shares (10 % of deal size) drew 105,939 valid applications, translating into 399.08 times oversubscription. • International Offering: 24.30 million shares (90 %) were 3.4 times subscribed across 129 placees. • No over-allotment option was granted; no post-listing stabilisation will be undertaken.

Capital base and public float Upon listing, COFOE will have 235.90 million shares in issue. The 27.00 million new H shares represent 11.67 % of the enlarged share capital, exceeding the minimum 10 % public-float requirement. After excluding cornerstone allocations subject to six-month lock-up, the free-float portion equals 17.35 million shares (7.50 % of total share capital) with an implied market value of approximately HK$682 million, satisfying the HKEX HK$600 million free-float rule.

Pricing metrics and investor mix • Cornerstone tranche: 9.65 million shares (35.76 % of the offer) were taken up by 12 investors, including Lens Technology (HK), Changsha Yufeng and Vision Capital, all subject to a six-month lock-up. • Concentration: The top 10 placees received 14.36 million shares, or 53.17 % of the total offer. The largest single placee was allocated 3.94 million shares (1.67 % of enlarged share capital). • Controlling shareholders will collectively hold 47.82 % of voting rights post-listing and are locked up for 12 months (split into two six-month periods).

Key dates and trading details • Share certificates become valid at 8:00 a.m. on 6 May 2026, with dealings in board lots of 100 H shares. • Stock code: 01187; stock short name: COFOE MEDICAL.

Regulatory compliance The company confirms adherence to HKEX Listing Rules for share allocation, public float and connected-party transactions, with waivers and consents secured where applicable.

This completes the final offer price and allotment disclosure ahead of COFOE’s debut on the Hong Kong Stock Exchange.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment